Trasti H, Nilsson S, Peterson L E
Br J Urol. 1979 Apr;51(2):135-9. doi: 10.1111/j.1464-410x.1979.tb02847.x.
Ii is shown from statistical data reported to the Swedish Cancer Registry that in cases of prostatic carcinoma the long-term T-year survival rate is the final outcome of a complex interplay of multiple factors including diagnostic technology and techniques for staging and grading. Assessment of the value of specific therapy is not possible except in controlled clinical trials. The T-year survival rate per se does not give an accurate estimate of the effect of treatment.
向瑞典癌症登记处报告的统计数据表明，在前列腺癌病例中，长期T年生存率是多种因素复杂相互作用的最终结果，这些因素包括诊断技术以及分期和分级技术。除非在对照临床试验中，否则无法评估特定治疗的价值。T年生存率本身并不能准确估计治疗效果。
